Full Press Release Details
Cameron Turtle , Chief Executive Officer, will participate in the Inflammation & Immunology Corporate Panel Discussion on Tuesday, March 5, 2024 , at 2:10 p.m. Eastern time .
To access this webcast, please visit the "Events & Presentations" page within the Investors section of the Spyre website at ir.spyre.com. An archive of the webcast will be available for replay for 30 days following the end of the conference.
About Spyre Therapeutics
Follow Spyre Therapeutics on social media: @spyretx and LinkedIn
For Investor s : Eric McIntyre VP of Finance and Investor Relations Spyre Therapeutics [email protected]
For Media : Peg Rusconi Peg.rusconi@vergescientific. com
SOURCE Spyre Therapeutics, Inc.